208 related articles for article (PubMed ID: 21295201)
1. Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma.
Patnana M; Bronstein Y; Szklaruk J; Bedi DG; Hwu WJ; Gershenwald JE; Prieto VG; Ng CS
Clin Radiol; 2011 Mar; 66(3):224-36. PubMed ID: 21295201
[TBL] [Abstract][Full Text] [Related]
2. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.
Pfannenberg C; Aschoff P; Schanz S; Eschmann SM; Plathow C; Eigentler TK; Garbe C; Brechtel K; Vonthein R; Bares R; Claussen CD; Schlemmer HP
Eur J Cancer; 2007 Feb; 43(3):557-64. PubMed ID: 17224266
[TBL] [Abstract][Full Text] [Related]
3. Imaging of abdominal manifestations of melanoma.
Kamel IR; Kruskal JB; Gramm HF
Crit Rev Diagn Imaging; 1998 Dec; 39(6):447-86. PubMed ID: 9885779
[TBL] [Abstract][Full Text] [Related]
4. [The latest diagnostical methods and therapy in melanoma].
Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
[TBL] [Abstract][Full Text] [Related]
5. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
6. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in sentinel lymph node-positive melanoma.
Miranda EP
J Clin Oncol; 2006 Nov; 24(32):5178; author reply 5178. PubMed ID: 17093288
[No Abstract] [Full Text] [Related]
7. Imaging in cutaneous melanoma.
Ho Shon IA; Chung DK; Saw RP; Thompson JF
Nucl Med Commun; 2008 Oct; 29(10):847-76. PubMed ID: 18769303
[TBL] [Abstract][Full Text] [Related]
8. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
Aloia TA; Gershenwald JE; Andtbacka RH; Johnson MM; Schacherer CW; Ng CS; Cormier JN; Lee JE; Ross MI; Mansfield PF
J Clin Oncol; 2006 Jun; 24(18):2858-65. PubMed ID: 16782925
[TBL] [Abstract][Full Text] [Related]
9. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma.
Müller-Horvat C; Radny P; Eigentler TK; Schäfer J; Pfannenberg C; Horger M; Khorchidi S; Nägele T; Garbe C; Claussen CD; Schlemmer HP
Eur J Cancer; 2006 Feb; 42(3):342-50. PubMed ID: 16364631
[TBL] [Abstract][Full Text] [Related]
10. Imaging of metastatic melanoma.
King DM
Cancer Imaging; 2006 Dec; 6(1):204-8. PubMed ID: 17208677
[TBL] [Abstract][Full Text] [Related]
11. Management of cutaneous melanoma.
Miranda EP
N Engl J Med; 2004 Dec; 351(26):2770-1; author reply 2770-1. PubMed ID: 15619744
[No Abstract] [Full Text] [Related]
12. Sentinel lymph node excision and positron emission tomography and computed tomography in the initial stage of malignant melanoma.
Hafner J
Dermatol Surg; 2010 Dec; 36(12):2082-3. PubMed ID: 21126282
[No Abstract] [Full Text] [Related]
13. Metastatic malignant melanoma.
Markovic SN; Erickson LA; Flotte TJ; Kottschade LA; McWilliams RR; Jakub JW; Farley DR; Tran NV; Schild SE; Olivier KR; Vuk-Pavlovic S; Sekulic A; Weenig RH; Pulido JS; Quevedo JF; Vile RG; Wiseman GA; Stoian I; Pittelkow MR;
G Ital Dermatol Venereol; 2009 Feb; 144(1):1-26. PubMed ID: 19218908
[TBL] [Abstract][Full Text] [Related]
14. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
15. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma.
Falk MS; Truitt AK; Coakley FV; Kashani-Sabet M; Hawkins RA; Franc B
Nucl Med Commun; 2007 Apr; 28(4):273-80. PubMed ID: 17325590
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT.
Laurent V; Trausch G; Bruot O; Olivier P; Felblinger J; Régent D
Eur J Radiol; 2010 Sep; 75(3):376-83. PubMed ID: 19497694
[TBL] [Abstract][Full Text] [Related]
17. Gallbladder metastasis from malignant melanoma: diagnosis with FDG PET/CT.
Rehani B; Strohmeyer P; Jacobs M; Mantil J
Clin Nucl Med; 2006 Dec; 31(12):812-3. PubMed ID: 17117082
[TBL] [Abstract][Full Text] [Related]
18. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET).
Servois V; Mariani P; Malhaire C; Petras S; Piperno-Neumann S; Plancher C; Levy-Gabriel C; Lumbroso-le Rouic L; Desjardins L; Salmon RJ
Eur J Surg Oncol; 2010 Feb; 36(2):189-94. PubMed ID: 19775851
[TBL] [Abstract][Full Text] [Related]
19. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
[TBL] [Abstract][Full Text] [Related]
20. Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-up.
Aukema TS; Olmos RA; Korse CM; Kroon BB; Wouters MW; Vogel WV; Bonfrer JM; Nieweg OE
Ann Surg Oncol; 2010 Jun; 17(6):1657-61. PubMed ID: 20151211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]